Pulmonary Hypertension Care Centers
The Pulmonary Hypertension Association’s Scientific Leadership Council, 28 global leaders in the field of pulmonary hypertension, have spearheaded the PHA-Accredited PH Care Centers (PHCC) initiative to establish a program for accreditation of centers with special expertise in pulmonary hypertension (PH), particularly pulmonary arterial hypertension (PAH), to raise the overall quality of care and outcomes in patients with this life-threatening disease.
Why Accreditation is Needed
Once considered rapidly fatal, PAH can now be treated with many medications, all developed in just the past two decades. Despite medical advances, the median time from onset of symptoms to PAH diagnosis is still 1.1 years, and many patients will see three or more different physicians over this period before they are properly diagnosed. Since early 2011, PHA’s Scientific Leadership Council has developed the PHCC initiative to assure outstanding care in pulmonary hypertension.
More Information
The PHA-Accredited PH Care Centers (PHCC) program is an initiative of PHA’s Scientific Leadership Council to accredit centers in the U.S. in order to raise the level of care for individuals with pulmonary hypertension (PH). Accreditation is based on a center’s overall commitment to PH patients, breadth of involved health care professionals and scope of services provided.
How to Find a PH Specialist In the PHCC Network
PHA has created a map to assist in locating a PHCC near you.
Map of accredited PH care centers
PH specialists in the PHCC network also can be found in our Doctors Who Treat PH directory. They will be designated as part of an accredited PH program in your search.
How PH Care Centers Are Expected to Improve Your Medical Care
- Patients are better informed about comprehensive PH care
- Patients have improved access to Centers with expertise in PH
- Patients experience less time between symptom onset and diagnosis
- A medical community better informed about standards of PH care
- Therapies are appropriately used to improve long-term outcomes
- Increased opportunities for collaboration between Centers for clinical care and PH research
The Two Types of Centers
Two types of centers are accredited: Centers of Comprehensive Care (CCC) and Regional Clinical Programs (RCP). Both accredited CCCs and RCPs will have demonstrated a commitment to providing expert-level care based on pulmonary arterial hypertension (PAH) consensus guidelines.
Centers of Comprehensive Care
A PHA-Accredited Center of Comprehensive Care is a highly organized, full-time PH Center that proficiently evaluates PH patients based on published evidence-based guidelines and also provides expert treatment of pulmonary arterial hypertension (PAH) patients with all of the FDA-approved therapies. CCCs also make important contributions to PH research and education.
Regional Clinical Programs
A PHA-Accredited Regional Clinical Program is a regional PH Center that proficiently evaluates PH patients based on published evidence-based guidelines and also provides expert treatment of PAH patients with all non-parenteral therapies. An RCP must collaborate with its regional CCCs by referring patients that may benefit from opportunities unavailable at the RCP, including the initiation of advanced parenteral therapies and participation in clinical research protocols.
Developing and Implementing the PHCC Program
In September 2011, members of the PHA Board of Trustees, the PHA Scientific Leadership Council, and other key stakeholders in the PH community approved the PHCC initiative in concept. A steering committee and task forces were organized and staffed to address accreditation criteria, program implementation, registry development, communication to key stakeholders and financial sustainability. The members below provided valuable contributions, which include: researching, accumulating and documenting information, developing logic models, defining action steps, building financial projections and validating the program content.
| Murali Chakinala, MD (PHCC Chair) | Washington University in Saint Louis |
| Rino Aldrighetti | PHA |
| Richard Channick, MD | Harvard Medical School |
| C. Gregory Elliott, MD | University of Utah |
| Serpil Erzurum, MD | The Cleveland Clinic Foundation |
| Karen Fagan, MD | University of South Alabama |
| Bob Gray | PHA |
| Michael Patrick Gray, MPH | PHA |
| Carl Hicks | PHA |
| Wendy Hill, RN, MSN | VA Greater LA Healthcare System |
| Steven Kawut, MD, MS (Patient Registry Task Force Chair) | University of Pennsylvania |
| Vallerie McLaughlin, MD | University of Michigan |
| Stephen Mathai, MD, MHS | Johns Hopkins University |
| Olivia Onyeador, MHA | PHA |
| Ron Oudiz, MD (Criteria Task Force Chair) | Harbor UCLA Medical Center |
| Abby Poms, RRT, RCP (Implementation Task Force Co-Chair) | Duke University |
| Jeffrey Sager, MD, MSCE | Cottage Hospital |
| Robert Schilz, DO, PhD | Case Western Reserve University |
| Traci Stewart, RN, MSN | University of Iowa |
| Darren Taichman, MD | University of Pennsylvania |
| Victor Tapson, MD | Cedars-Sinai |
| Corey Ventetuolo, MD, MS | Brown University |
| Joel Wirth, MD (Implementation Task Force Co-Chair) | Maine Medical Center |
| Roham Zamanian, MD (Funding Task Force Chair) | Stanford University |
PHCC Initiative Mission Statement
The purpose of the PHA-Accredited Pulmonary Hypertension Care Centers (PHCC) initiative is to establish a program of accredited centers with expertise in pulmonary hypertension that aspires to improve overall quality of care and ultimately improve outcomes of patients with pulmonary hypertension, particularly pulmonary arterial hypertension, a rare and life-threatening group of diseases.
Why the Need for Accreditation?
Despite the availability and success of PAH-targeted therapeutic options over the past two decades, there are still shortcomings with the diagnosis and management of PAH. One recent study observed that expert recommended diagnostic algorithms were not being followed to completion in up to 94% of PAH patients, and nearly 60% of PAH referrals to expert centers already on therapy were on so contrary to published guidelines. In addition, despite the available medical therapies, long-term outcomes are still not optimal as many patients still die from PH, require transplantation or require hospitalization.
PH Care Centers: What You Need to Know
Two types of centers are be accredited: Centers of Comprehensive Care (CCC) and Regional Clinical Programs (RCP). Please note that applications for Pediatric Regional Clinical Programs are not currently being accepted. Learn more about the PH Care Centers initiative:
- Application Process
- Accreditation Criteria
- Frequently Asked Questions
- Informational Webinars
- PHCC Medical Leadership
- Get Involved
PHCC News and Research
Advisory: Reproductive Health and Pulmonary Hypertension
Pregnancy is considered high risk for people with pulmonary hypertension because their heart and lungs can’t easily adjust to the demands of pregnancy and childbirth.
Brigham and Women’s Hospital and Harvard Medical School
The Burke Advanced Fellowship in Pulmonary Heart Disease at The Brigham and Women’s Hospital and Harvard Medical School—invites applications for an advanced fellowship in pulmonary heart disease starting July 1, 2025. This training program is sponsored by the Center for Pulmonary Heart Disease at the Brigham and Women’s Hospital.
Transplant Recipient Aids Research Through Own Gift
Lauri Stanfield of Tomball, Texas, received the gift of life in 2015 through a double lung transplant – and gave life by donating parts of her lungs for research. Stanfield, who works in the oil industry, likes to try new things and is weighing whether to learn pickle ball.
Making a Splash With Subcutaneous Therapy
Tiffani Brown was dismayed to give up water activities when she started subcutaneous treprostinil therapy in 2020. Since then, she worked with her pulmonary hypertension nurse Debbie Kittel to find a way to keep her site dry while swimming and showering.
Don’t Miss Last Day To Sign Up for Virtual Advocacy Event
Today -- April 10 – is your last chance to sign up for May 7 virtual advocacy visits. The virtual advocacy visits mark World PH Day by educating lawmakers about pulmonary hypertension.
Join an O2breathe Walk in Your Area
The Pulmonary Hypertension Association’s O2breathe walks are in full swing. Our fundraising walks bring PH communities together to celebrate their accomplishments and raise money for PHA.
Your Tax-Smart Gift Can Power the Next PH Breakthrough
With NIH cuts and rising demand for PH research funding, your support is more vital than ever. As Tax Day approaches, consider tax-smart giving options that can maximize your impact and offer potential tax benefits.
New Pathlight Honors PH Heroes
The latest issue of Pathlight magazine celebrates pulmonary hypertension heroes. As National Volunteer Month approaches, PHA acknowledges the people who make this organization a success. This issue also includes articles about imaging innovations, managing medication side effects and swimming with subcutaneous therapy.
San Antonio Support Group Leader Finds Community Through PHA
Over the past 24 years, Sophia Esteves of San Antonio has found strength and community through the Pulmonary Hypertension Association. Last year, PHA named Esteves its 2024 Outstanding Support Group Leader. Esteves shares her story as the face of PHA’s spring fundraising campaign and in the upcoming issue of Pathlight magazine.
PHA Advocacy Improves Therapy Access in Arizona
Thanks to Pulmonary Hypertension Association advocacy, Arizona reduced some step therapy requirements. Medicaid beneficiaries now have to try only two preferred PH mediations instead of three under the state’s strict coverage rules.
Support Groups in the COVID Era: ‘Keeping Sane During a Scary Time’
Before the COVID-19 pandemic, most Pulmonary Hypertension Association support group meetings took place in person. So PHA and its volunteer leaders came up with ways to meet via computer, and many groups still offer that option.
PHA Grants Now Require Letters of Intent
The Pulmonary Hypertension Association has streamlined its research grant selection process. It now requires all grant applicants to submit letters of intent before they apply. The new process identifies promising research proposals early and will speed up the review process. Applicants will receive feedback earlier so they can refine their proposals.
PHA Accredits 3 New PH Care Centers
The Pulmonary Hypertension Association welcomes three new institutions to its network of accredited PH Care Centers.
Melinda L. (she/her)
Melinda was diagnosed with PH in 2019 and works part time. She lives in the US Southeast. Melinda has CREST syndrome, which includes scleroderma.
New Challenges Threaten Care Access Since Pandemic
Five years after the World Health Organization declared COVID-19 to be a pandemic, new challenges threaten access to affordable health care, critical research and the wellbeing of the PH community. During these unsettling times, the Pulmonary Hypertension Association continues to advocate for policies that guarantee access to quality care.
A decade of impact: PHAR marks 10 years of PH advancing PH research
This year marks the 10th anniversary of the Pulmonary Hypertension Association Registry, a critical resource that now includes data from more than 3,500 patients. Over the past decade, PHAR has empowered health care providers and researchers to drive evidence-based practice, improve patient care and fuel innovations in treatment.
Flashback Thursday: 8 Reminders of Resilience During the Pandemic
Five years ago, the World Health Organization declared a new, rapidly spreading respiratory virus to be a pandemic. While physically distancing themselves, the pulmonary hypertension community came together in mind and spirit. The Pulmonary Hypertension Association captured those stories and more. Read on to revisit eight accounts of how the PH community adapted to the pandemic.
Time is Running Out To Register for PH Community Workshop
Have you secured your spot at PHA’s March 22 PH Community Workshop in Charlotte, North Carolina? Register online by Friday, March 14 to secure your spot. Space is limited, so don’t miss this opportunity to connect with the PH community , hear from PH experts, and discover invaluable resources.
Researchers: Apply for PHA Grants
The Pulmonary Hypertension Association encourages PH professionals to apply for two research grants: the Health Disparities in PH Research and Innovation in PH Research awards. The Health Disparities in PH Research grant supports projects that addresses early diagnosis, education and improving clinical outcomes and treatments for people with PH who may be affected by health inequities.